Search for: "Beckman Coulter" - 84 articles found

Photo

Dry Unitized Reagent Assays

Beckman Coulter presents online cost benefit tool at AACC 2019

Beckman Coulter Life Sciences launched the online DURA Innovations calculator tool, a powerful cost benefit analysis resource to accompany its latest Cost Benefit Calculator Handbook. The free online tool enables laboratories to quantify the value of converting to a standardized flow cytometry workflow using the company’s dry reagent technology. The new calculator enables customers using liquid…

Photo

Flow cytometry lab

New ClearLLab IVD Reagents launched

Beckman Coulter is launching the ClearLLab 10C System for the clinical flow cytometry lab. The new system is the first 10-color IVD panel of immunophenotyping reagents cleared by the Food and Drug Administration (FDA) for both lymphoid and myeloid lineages. The four dry pre-mixed antibody tubes use the company’s DURA Innovations technology, eliminating the need to pipette antibodies, improving…

Photo

Hematology

Early sepsis indicator helps identifying patients at risk

The critical element of testing for sepsis lies not so much in the location but in the timing and rapidity of results, according to Professor Jeannine T. Holden from Beckman Coulter Early identification enables treatment protocols to be delivered more quickly, offering better patient outcomes. Those most at risk, suggests Holden, are not patients within the intensive care unit – who are already…

Photo

Total Laboratory Automation

TLA sets new standard for turnaround time

Beckman Coulter announced that the latest addition to its market-leading automation portfolio, the DxA 5000 total laboratory automation (TLA) solution has achieved European CE Mark and China Food and Drug Administration approval. In today’s healthcare environment, laboratories are highly focused on enhancing patient care by driving faster turnaround time, delivering quality results and…

Photo

Symposium @ ECCMID 2019

How laboratories can help detect AMR and sepsis sooner

Beckman Coulter, a global leader in clinical diagnostics will be demonstrating its latest comprehensive solutions in microbiology, urinalysis and hematology at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID). During the conference, Beckman Coulter is also hosting a symposium where attendees will learn how the laboratory can help physicians detect…

Photo

New hematologic biomarker

FDA clearance for early sepsis indicator

A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). Sepsis is a global healthcare crisis that affects more than 30 million people worldwide. The Early Sepsis Indicator is a first-of-its-kind, hematology-based cellular biomarker that is…

Photo

World Sepsis Day 2018

Beckman Coulter sponsored 2nd World Sepsis Congress

Beckman Coulter was a gold sponsor of the 2nd World Sepsis Congress, a free-of-charge online conference, hosted by the Global Sepsis Alliance, that took place on Sept. 5 and 6, 2018. Over the course of 17 sessions, more than 100 speakers from approximately 30 countries discussed the wide-ranging implications of sepsis and how to raise public awareness of this often-fatal condition.

Photo

Diagnostic lab system

DxM MicroScan WalkAway System now available on the market

Beckman Coulter announced commercialization of its DxM MicroScan WalkAway system, a diagnostic solution for bacterial identification and antibiotic susceptibility testing for microbiology laboratories. The DxM MicroScan WalkAway system uses direct minimum inhibitory concentrations (MIC) for detection of antimicrobial resistance, offering greater confidence in results through gold-standard…

Photo

Innovation

Hematology: Advancements and future trends

While the role of the laboratory in disease diagnosis and management has expanded in recent years, causing an overwhelming rise in testing demands, the availability of skilled technologists and specialists has been diminishing. To meet the needs of an overworked and increasingly generalized workforce, today’s products not only must deliver more clinical data than ever before, but also must be…

Photo

Clinical guide app

Sepsis app continues through sponsoring

Beckman Coulter announced its exclusive sponsorship of the ESCAVO Sepsis Clinical Guide (Sepsis app), a point-of-care medical reference mobile application for healthcare professionals who manage septic patients in acute-care settings. Beckman Coulter’s sponsorship of the Sepsis app ensures that the tool will remain free for all users and that content will continue to be maintained and updated…

Photo

Workflow

Confidence in Hematology, Results with Beckman Coulter

Wallace Coulter, one of the founders of Beckman Coulter, was motivated by a belief that science should serve humanity. This was the inspiration behind the principle he invented that became the basis for all blood counting solutions. This same drive to keep the science of hematology moving forward is behind Beckman Coulter's new ©Automated Intelligent Morphology© (AIM), a multidimensional,…

Photo

Beckman Coulter to aquire lab-based Diagnostics business from Olympus Corporation

Beckman Coulter, Inc., a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical tests, and Olympus Corporation, a Tokyo-headquartered precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, announced today that they have entered into a definitive agreement…

Photo

Beckman Coulter - PROService

technology More Beckman Coulter, Inc.Beckman Coulter - PROService PROService is Beckman Coulter's secure remote management and diagnostics system that enables the transfer and analysis of performance
Photo

Beckman Coulter Launches the UniCel® DxI 600 at EuroMedLab 2007

Beckman Coulter, Inc. has launched the next analyser in its series of in vitro diagnostic offerings, the UniCel® DxI 600 Access® Immunoassay System, an innovative immunochemistry instrument designed for mid-volume laboratories, a segment which represents more than 45 percent of the immunodiagnostic testing market, worldwide.

Photo

Beckman Coulter – DxA 5000

& sample processing More Beckman Coulter, Inc.Beckman Coulter – DxA 5000 Dynamic inlet: Up to 1,200 tubes / hCentrifuges:  Up to 500 tubes / h (1),Up to 500 tubes / h (2)Decapper: Up to 1,200 tubes
Photo

Beckman Coulter Launches the UniCel® DxI 600

Beckman Coulter has launched the next analyzer in its growing family of UniCel® systems, the UniCel DxI 600 Access® Immunoassay System. This instrument is designed for mid-volume laboratories, a segment which represents more than 45 percent of the immunodiagnostic testing market, worldwide.

Photo

Beckman Coulter – Access Active B12

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – Access Active B12 Highlights:The WHO standardized Access Active-B12 assay is Beckman Coulters’ newest addition to the most comprehensive anemia
Photo

Beckman Coulter – Access Procalcitonin (PCT)

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – Access Procalcitonin (PCT) Highlights:Access PCT aids physicians in the risk assessment of ­critically ill patients for progression to severe
Photo

Beckman Coulter - HematoFlow

Beckman Coulter, Inc.Beckman Coulter - HematoFlow HematoFlow is a unique cellular analysis solution which brings automated flow cytometry testing into the routine, mid to large haematology laboratory
Photo

Beckman Coulter – Anti-Mullerian Hormone (AMH)

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – Anti-Mullerian Hormone (AMH) Highlights:Beckman Coulter’s automated Access AMH assay aids healthcare providers in the assessment of a woman’s
Photo

Beckman Coulter – phi (Prostate Health Index)

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – phi (Prostate Health Index) Highlights:Beckman Coulter’s Prostate Health Index (phi) helps distinguish prostate cancer from benign conditions
Photo

Beckman Coulter – HbA1c Advanced

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – HbA1c Advanced Highlights:The fully automated HbA1c Advanced assay enables mid- to high-volume laboratories to provide physicians with state
Photo

Beckman Coulter – AU5800 Series

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – AU5800 Series Dimensions: 1260 x 2600 x 1580 mm (h x w x d)Weight: 1070 kgSample throughput: 2000 - 9800/hPower consumption: 200 - 240
Photo

Beckman Coulter – HbA1c Advanced

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – HbA1c Advanced Highlights:The fully automated HbA1c Advanced assay enables mid- to high-volume laboratories to provide physicians with state
Photo

Beckman Coulter – Remisol Advance

technology More Beckman Coulter, Inc.Beckman Coulter – Remisol Advance Highlights:Remisol Advance is an enterprise data management solution that can help improve sample workflow through consolidated
Photo

Beckman Coulter – Access 25(OH) Vitamin D Total

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – Access 25(OH) Vitamin D Total Highlights:The Access 25(OH) Vitamin D Total assay is part of ­Beckman Coulter’s Bone Metabolism port­folio
Photo

Beckman Coulter sold

USA - Over the past couple of decades, due to acquisitions California-based Beckman Coulter Inc has became one of the world’s largest manufacturers of in vitro diagnostics analysers and automation for clinical pathology laboratories. Now, in a US$6.8 billion transaction, including debt and cash acquired, the company itself been acquired by the Danaher Corporation of Washington, D.C.

Photo

Beckman Coulter - Iris iRICELL Series

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter - Iris iRICELL Series Sample throughput: Up to 70 samples/h (microscopy)Up to 210 samples/h (chemistry)The Iris iRICELL2000, available from
Photo

Beckman Coulter – Early Sepsis Indicator

Beckman Coulter, Inc.Beckman Coulter – Early Sepsis Indicator Highlights:A first-of-its-kind, hematology-based cellular biomarker, the Early Sepsis Indicator is designed to help emergency department
Photo

Beckman Coulter - Power Link Workcell

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter - Power Link Workcell Parallel processing of shared chemistry and ­0immunoassay specimensSingle point of loading and unloading for shared
Photo

Beckman Coulter – DxC 700 AU

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – DxC 700 AU Dimensions: 1,300 × 1,250 × 890 mm (h × w × d)Weight: 460 kgSample throughput: 800 – 1,200 / hPower consumption: 200 – 240
Photo

Beckman Coulter – DxH 520 Hematology Analyzer

Beckman Coulter, Inc.Beckman Coulter – DxH 520 Hematology Analyzer Dimensions:270 × 404 × 430 mm (w × h × d)Weight:11.4 kgSample throughput:60 samples / h Open vial;55 samples / h Cap piercePower
Photo

Beckman Coulter – DxH 900 Hematology Analyzer

Beckman Coulter, Inc.Beckman Coulter – DxH 900 Hematology Analyzer Dimensions: 755.7 × 1,740 × 828 mm (w × h × d)Weight: 254 kgSample throughput: Up to 100 samples / hPower consumption: 520
Photo

Beckman Coulter – Access 2 Immunoassay System

& immunochemistry More Beckman Coulter, Inc.Beckman Coulter – Access 2 Immunoassay System Dimensions: 500 × 900 × 610 mm (h × w × d)Weight: 97 kgSample throughput: Up to 100 / hAssays: > 50 pre-programmed
Photo

Cloud computing

New tools to ease lab work

Beckman Coulter Diagnostics introduces a new integrated system of technologies and capabilities called DxONE, designed to ease data access and usability. DxONE was created in response to the increasing challenges faced by laboratory technicians to expedite result times, reduce costs, maneuver personnel shortages and navigate network consolidations.

Photo

Molecular diagnoses will become routine

Molecular diagnostics is one of the most important technological advances in clinical diagnostics, seeing the €3.6 billion market grow 10% in constant currency (CC) in 2010 and predicted continual growth well above the diagnostic industry rates. The recipe for success in this field lies in three critical components: core technology, automation and menu. During our interview with Marc Meyer, the…

Photo

New study

Prostate Health Index drastically cuts down biopsy rate

A study published in Prostate Cancer and Prostatic Diseases demonstrated that physicians elected to perform fewer biopsies when Prostate Health Index (phi) testing was included in their overall, routine, clinical assessment. Phi testing is recommended for men presenting with elevated serum total prostate-specific antigen (PSA) in the 4-10 ng/mL range and a non-suspicious digital rectal exam…

Photo

A journey towards full automation

St Jude Medical Center, in Fullerton, California, has always taken pride in its reputation as one of Southern California’s most respected and technologically advanced hospitals. With 384 licensed beds and over 700 physicians the centre offers a comprehensive array of services and programmes, including cardiac, stroke care, a breast and cancer centres, full maternity services, orthopaedic…

Photo

Partnership delivers improvements in pathology services

Southampton University Hospitals’ Department of Laboratory Medicine has recently transformed the way it delivers its pathology service, becoming one of the largest automation installations in the National Health Service to operate under a managed service contract. This has contributed significantly to the development of a strengthened and expanded pathology network across Southern England.

Photo

Best Places to Work

A laboratory fit for a future decade

Fostering a collaborative way of working won the UK’s Dartford and Gravesham NHS Trust recognition as an elite public sector healthcare employer, recently judged one of the top 100 ‘Best Places to Work’. The trust, led by chief executive Susan Acott, has created an energy-driven, patient-focused culture within the hospital, reflected by staff at all levels. This has been the driving force…

AACC 2010

California, USA: 20,000 visitors and 700 manufacturers showing products in almost 2000 booths at the American Association for Clinical Chemistry (AACC) annual meeting (July 5-29, 2010) underlined the importance of this, the world’s largest gathering of clinical laboratory professionals.

Photo

Data sharing

The LAW of the Lab

First they fixed the cables to hard-wire a faster data transfer from laboratory instruments. Now a coalition of the largest manufacturers of lab equipment for patient diagnostic tests have agreed on shared protocols for how software should report results. This is the first update to international standards in 20 years.

Photo

Laboratory automation

On the leading edge of automation for medical laboratory testing, Siemens Healthcare rolled out an impressive suite of new products at IFCC WorldLab 2014 in Istanbul, Turkey that are ‘exactly aligned, and even anticipate, customer needs in central lab operations,’ according to Franz Walt, CEO for the Chemistry, Immunoassay, Automation and Diagnostics IT business unit within Siemens’…

Photo

Changing the way we live

Marcel van Kasteel MBA, is VP of Philips and CEO of Handheld Immunoassays, a Philips Incubator venture in Eindhoven, the Netherlands, which recently announced that, by the end of this year, the first device to test for drug abuse will be marketed that will make on the spot testing simple and quick for use by the police.

Photo

AACC emphasises preventive diagnostics

San Diego, California - 20,000 international physicians, scientists and other visitors travelled to the Annual Meeting & Clinical Lab Expo of the American Association for Clinical Chemistry (AACC) in July, and 750 exhibitors emphasised the increasing importance of this gathering